Haroli: Himachal’s next pharma play
In Haroli, a quiet industrial location is being positioned at the centre of India’s next pharmaceutical shift. The Bulk Drug Park…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gujarat’s bet on Jambusar
Between the Gulf of Khambhat and the Narmada, India is staking 3,920 crores on the Jambusar Bulk Drug Park in Bharuch, Gujarat.…
JNPC: Carrying forward a 20-year old legacy
Billed as India’s first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private…
Genome Valley: Aligning with what comes next
For years now, the Indian pharma industry has been talking about moving beyond scale. The shift towards innovation and complex…
Holista executes binding JV for collie collagen facility
Holista Colltech is pleased to announce that it has entered into a binding Joint Venture Agreement with Swang Chai Chuan (SCC) for…
Anuh Pharma get prequalification nod from WHO for anti-malarial bulk drug
Anuh Pharma has received prequalification approval from World Health Organization (WHO) for anti-malarial active pharmaceutical…
Lupin receives US FDA approval for Glycerol Phenylbutyrate oral liquid
Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration for its…
OneSource supports second generic semaglutide approval in Canada
OneSource Specialty Pharma, a leading specialty pharmaceutical CDMO, announced that its partner Orbicular, along with its Canadian…
Indoco Remedies announces strategic transfer of its ophthalmic division to Sunways India
Indoco Remedies has announced that in the Board Meeting conducted on 30th April, it has considered and approved the transfer of…
CPHI & PMEC India 2026 expand to two venues in Delhi-NCR
As the global pharmaceutical industry steers into a phase defined by innovation, advanced manufacturing, automation, and deeper…